Liquidity & Technicals

Liquidity & Technicals — Reckitt Benckiser Group plc (RKT.L)

Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

A FTSE-100 mega-cap with deep ADV ($135M+ daily) but a tape that has just rolled over: price is 16.6% below the 200-day, a fresh death cross printed on 2026-04-16, and realized volatility has pushed back into the stressed regime. Liquidity is not the constraint here — execution timing is.

1. Portfolio implementation verdict

2. Price snapshot

The shares are at $64.27 — a hair above the 52-week low of $61.59 and 41% below the 52-week high of $87.72. The +3% trailing-12-month print masks a violent two-leg pattern: a Q4 2025 / Jan 2026 rally to ~$87, then a 27% collapse over February–April. Beta is reported approximate; consumer staples typically run 0.4–0.6 versus the FTSE 100.

3. The critical chart — price vs 50/200-day SMA (10-year history)

Price is 16.6% below the 200-day SMA ($77.07). This is a downtrend regime, not sideways. The 10-year picture shows the secular damage clearly: the stock peaked above $103 in mid-2017 and has lost the 200-day three times — late 2018, 2024 (post-Mead Johnson litigation) and again in 2026. Each lower top has held; the 200-day has not been reclaimed durably for two years.

4. Relative strength vs market

The benchmark series for the UK broad market (EWU) is not populated in this run, so the chart below shows RKT.L rebased to 100 at t=−756 trading days (April 2023) on a standalone basis. Read this as company drift, not as alpha versus an index — but the magnitude is striking enough to make the point on its own.

The shares are at index 74 — they have given back ~26% of the rebase value over three years even before benchmarking, with the round-trip from index 100 to 64 (March 2024 capitulation) to 101 (mid-February 2026) and back to 74 the dominant feature. Sponsorship has been transient: every push back toward old highs has met selling.

5. Momentum — RSI(14) + MACD histogram

RSI hit 19.8 on 2026-03-12 — a textbook deeply-oversold print, the lowest reading on the 18-month panel — and has rebuilt to 32.8 over the past six weeks. The MACD histogram bottomed at −119 in mid-March and has been working back toward zero, printing positive bars on 2026-04-02 / 04-13 / 04-20 before slipping to −10.8 at the snapshot. Net read: short-term oversold and stabilising on the daily, but no positive RSI divergence yet — price made a fresh low on 2026-04-23 even as RSI held above its March trough. That is reflexive bounce material, not an inflection.

6. Volume, volatility, and sponsorship

The 50-day average has stepped up from ~1.4M shares/day in mid-2025 to ~2.2M today — a 50% lift in active turnover that began with the October 30, 2025 spike (4.5x) and accelerated through Q1 2026. More volume on a falling tape is distribution, not accumulation.

Three of the five biggest 50-day-average volume blowouts since 2022 closed deep in the red, including the −14.6% drawdown of 15 March 2024. The two single-digit-decline days (2026-01-20 at 4.7x, 2025-10-30 at 4.5x) lined up at price highs of the recent range and preceded the February–April 2026 collapse — the "quiet" high-volume days were unloads under cover of strength, not arrivals.

Realized vol prints 30.2% today versus 10-year percentile bands of p20 = 14.3%, p50 = 18.8%, p80 = 25.5%. The last six weeks have pushed back into the stressed regime (above p80) — the same band that contained the April 2024 Mead Johnson litigation shock (66%) and the August 2024 capacity cuts (32%). On a defensive consumer-staples name, 30% realized vol is not a margin-of-safety regime; it is forced volatility from a narrow set of holders rerating their position size.

7. Institutional liquidity panel

This section answers a single question: can an institutional fund act in this stock at meaningful size? On the absolute-shares-traded math, the answer is yes. On the issuer-level "% of market cap" view, the data set is incomplete — share count and market cap are not populated in liquidity.json, which sets the verdict to "Liquidity unknown" — so the runway table below is shown in absolute dollar capacity rather than as a percent of float. Treat the absolute numbers as the primary read.

A. ADV and turnover

ADV stepped up from 60-day to 20-day on shares (1.38M → 2.00M shares/day, +44%) but value-weighted ADV slipped ($170.5M → $135.5M) because the share-price decline outweighed the volume rise — i.e. holders are selling more units, but each unit is worth less. Turnover-as-percent-of-market-cap is unavailable, but on the FTSE-100 reference base of approximately $44B market cap implied by share-capital and EPS data, ADV runs near 0.30%–0.35% of mcap (roughly 75–90% annual turnover).

B. Fund-capacity table

At a normal 20%-ADV participation rate, RKT.L can absorb a $129M five-day build-or-exit. That sustains a 5% position for funds up to $2.57B AUM and a 2% position for funds up to $6.43B. At a more conservative 10% participation, halve everything — capacity falls to $64.3M over five days and 5% position support falls to $1.29B AUM. For UK and global income-style mandates that typically run 1.5%–3% in a single staple, this is comfortable headroom up to mid-cap multi-manager scale.

C. Liquidation runway by absolute position size

Because issuer-level mcap-relative data is missing, the table below is anchored on absolute dollar positions rather than % of mcap.

Days-to-exit math: position shares ÷ (ADV 20d × participation rate), rounded up. Reading the lines: a $135M position is a two-week exit at 20% ADV, while a $673M block runs five weeks at 20% participation or ten weeks at 10%. Anything beyond ~$337M starts to look like a multi-quarter unwind under stress.

D. Execution friction

The 60-day median daily price range is 2.21% — fractionally above the 2% threshold the brief flags as elevated. For context, this is the trough-to-peak range on a typical session, not a transaction-cost bid-ask spread, but it implies that intraday timing matters: a buy or sell crossed against the wrong half of the range costs roughly a full point in price. Combined with 30% annualised realized vol, expected impact on a one-day $27–34M block is non-trivial — phase across multiple sessions or use blocks rather than chasing the close.

Bottom line on liquidity: at 20% ADV, the largest size that clears the 5-day threshold is $129M; at 10% ADV (the more conservative buy-side standard) it falls to $64M. Liquidity is not the constraint; the technical setup is.

8. Technical scorecard and stance

Stance — bearish, 3-to-6 month horizon. The tape is in a confirmed downtrend with a fresh death cross, distribution-pattern volume, stressed realized vol, and a price that has just made a 52-week low. The single counter-current is a deeply oversold RSI off 19.8 with a recovering MACD histogram — adequate for a tactical bounce of one to three weeks, not for an inflection. Bullish invalidation: a daily close back above $74.58 (the 50-day SMA) on rising rather than falling volume — that would re-engage the prior uptrend and force a re-read. Bearish confirmation: a daily close below $61.59 (52-week low) — the next visible support is the all-time low at $54.32 set in earlier years. Liquidity is not the constraint; the right action is to wait. Build only after a structural change in the tape — either reclaim of $74.58 with volume, or a clean $61.59 flush followed by an absorption print in the $54–57 zone.